NewsRx

Search our medical news database

Greyson International, Inc.

Greyson International, Inc. Appoints Director of Medical Products

Published in Healthcare Finance, Tax and Law Weekly, June 10th, 2009

Greyson International, Inc. (GYSN.PK) announced that it has appointed Dr. Daniel Ettedgui, D.O., as its Director of Medical Products.

Ettedgui is a practicing physician in Florida, specializing in physical medicine and rehabilitation. He is board certified by the American Board of Physical Medicine and Rehabilitation, and a is member of the American Academy of Pain Management and the American Academy of Physical Medicine and Rehabilitation, among others. Ettedgui is a graduate of Nova Southeastern University and Davidson College.

A newly created position, the Director of Medical Products will work to research and develop topical products, both...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook